{"id":21759,"date":"2016-11-22T08:17:36","date_gmt":"2016-11-22T02:47:36","guid":{"rendered":"https:\/\/cardiophile.org\/?p=21759"},"modified":"2021-12-20T22:44:41","modified_gmt":"2021-12-20T17:14:41","slug":"drug-for-pda-closure-in-newborn-cardiology-mcq","status":"publish","type":"post","link":"https:\/\/johnsonfrancis.org\/professional\/drug-for-pda-closure-in-newborn-cardiology-mcq\/","title":{"rendered":"Drug for PDA closure in newborn – Cardiology MCQ"},"content":{"rendered":"
\n
\n
\n
\n
\n
\n
\nWhich of the following is not meant for closure of patent ductus arteriosus in a newborn baby?<\/b><\/span>\n<\/div>\n

a) Paracetamol\n<\/p><\/div>\n

b) Prostaglandin E1\n<\/p><\/div>\n

c) Ibuprofen\n<\/p><\/div>\n

d) Indomethacin\n<\/p><\/div>\n

Correct answer: b) Prostaglandin E1<\/b><\/span>\n<\/div>\n

Prostaglandin E1 is used for maintaining ductal patency in ductus dependent circulations [1]. Both oral [2] and intravenous paracetamol [3] have been used for pharmacological closure of patent ductus arteriosus<\/em> in newborns. Indomethacin was the earlier drug being used for pharmacological ductal closure, but seldom used now because of its adverse effect. Then came ibuprofen, which is still being used. Paracetamol is the latest addition, with a better side effect profile than ibuprofen.\n<\/div>\n

Ductus dependent circulations are classified into ductus dependent pulmonary circulations and ductus dependent systemic circulations. Both worsen after birth at the time of spontaneous ductal closure.<\/div>\n

Reference<\/b>
\n1. Huang FK, Lin CC, Huang TC, Weng KP, Liu PY, Chen YY, Wang HP, Ger LP, Hsieh KS. Reappraisal of the prostaglandin E1 dose for early newborns with patent ductus arteriosus-dependent pulmonary circulation. Pediatr Neonatol. 2013 Apr;54(2):102-6.
\n2. Bagheri MM, Niknafs P, Sabsevari F, Torabi MH, Bahman Bijari B, Noroozi E, Mossavi H. Comparison of Oral Acetaminophen Versus Ibuprofen in Premature Infants With Patent Ductus Arteriosus. Iran J Pediatr. 2016 May 15;26(4):e3975.
\n3. Valerio E, Valente MR, Salvadori S, Frigo AC, Baraldi E, Lago P. Intravenous paracetamol for PDA closure in the preterm: a single-center experience. Eur J Pediatr. 2016 Jul;175(7):953-66.<\/p>\n","protected":false},"excerpt":{"rendered":"

Which of the following is not meant for closure of patent ductus arteriosus in a newborn baby? a) Paracetamol b) Prostaglandin E1 c) Ibuprofen d) Indomethacin Correct answer: b) Prostaglandin E1 Prostaglandin E1 is used for maintaining ductal patency in ductus dependent circulations [1]. Both oral [2] and intravenous paracetamol [3] have been used for […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"nf_dc_page":"","footnotes":""},"categories":[2,3,5],"tags":[1217,2875],"class_list":["post-21759","post","type-post","status-publish","format-standard","hentry","category-cardiology","category-cardiology-mcq","category-dm-dnb-cardiology-entrance","tag-drug-for-pda-closure","tag-pharmacological-closure-of-patent-ductus-arteriosus"],"yoast_head":"\nDrug for PDA closure in newborn - Cardiology MCQ - All About Cardiovascular System and Disorders<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/johnsonfrancis.org\/professional\/drug-for-pda-closure-in-newborn-cardiology-mcq\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Drug for PDA closure in newborn - Cardiology MCQ - All About Cardiovascular System and Disorders\" \/>\n<meta property=\"og:description\" content=\"Which of the following is not meant for closure of patent ductus arteriosus in a newborn baby? a) Paracetamol b) Prostaglandin E1 c) Ibuprofen d) Indomethacin Correct answer: b) Prostaglandin E1 Prostaglandin E1 is used for maintaining ductal patency in ductus dependent circulations [1]. Both oral [2] and intravenous paracetamol [3] have been used for […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/johnsonfrancis.org\/professional\/drug-for-pda-closure-in-newborn-cardiology-mcq\/\" \/>\n<meta property=\"og:site_name\" content=\"All About Cardiovascular System and Disorders\" \/>\n<meta property=\"article:published_time\" content=\"2016-11-22T02:47:36+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-12-20T17:14:41+00:00\" \/>\n<meta name=\"author\" content=\"Johnson Francis\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Johnson Francis\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/drug-for-pda-closure-in-newborn-cardiology-mcq\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/drug-for-pda-closure-in-newborn-cardiology-mcq\\\/\"},\"author\":{\"name\":\"Johnson Francis\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\"},\"headline\":\"Drug for PDA closure in newborn – Cardiology MCQ\",\"datePublished\":\"2016-11-22T02:47:36+00:00\",\"dateModified\":\"2021-12-20T17:14:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/drug-for-pda-closure-in-newborn-cardiology-mcq\\\/\"},\"wordCount\":235,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\"},\"keywords\":[\"Drug for PDA closure\",\"pharmacological closure of patent ductus arteriosus\"],\"articleSection\":[\"Cardiology\",\"Cardiology MCQ\",\"DM \\\/ DNB Cardiology Entrance\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/drug-for-pda-closure-in-newborn-cardiology-mcq\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/drug-for-pda-closure-in-newborn-cardiology-mcq\\\/\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/drug-for-pda-closure-in-newborn-cardiology-mcq\\\/\",\"name\":\"Drug for PDA closure in newborn - Cardiology MCQ - All About Cardiovascular System and Disorders\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#website\"},\"datePublished\":\"2016-11-22T02:47:36+00:00\",\"dateModified\":\"2021-12-20T17:14:41+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/drug-for-pda-closure-in-newborn-cardiology-mcq\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/drug-for-pda-closure-in-newborn-cardiology-mcq\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/drug-for-pda-closure-in-newborn-cardiology-mcq\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Drug for PDA closure in newborn – Cardiology MCQ\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#website\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/\",\"name\":\"All About Cardiovascular System and Disorders\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":[\"Person\",\"Organization\"],\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\",\"name\":\"Johnson Francis\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\",\"caption\":\"Johnson Francis\"},\"logo\":{\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\"},\"description\":\"Former Professor of Cardiology, Calicut Govt. Medical Kozhikode, Kerala, India. Editor-in-Chief, BMH Medical Journal\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/author\\\/jf\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Drug for PDA closure in newborn - Cardiology MCQ - All About Cardiovascular System and Disorders","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/johnsonfrancis.org\/professional\/drug-for-pda-closure-in-newborn-cardiology-mcq\/","og_locale":"en_US","og_type":"article","og_title":"Drug for PDA closure in newborn - Cardiology MCQ - All About Cardiovascular System and Disorders","og_description":"Which of the following is not meant for closure of patent ductus arteriosus in a newborn baby? a) Paracetamol b) Prostaglandin E1 c) Ibuprofen d) Indomethacin Correct answer: b) Prostaglandin E1 Prostaglandin E1 is used for maintaining ductal patency in ductus dependent circulations [1]. Both oral [2] and intravenous paracetamol [3] have been used for […]","og_url":"https:\/\/johnsonfrancis.org\/professional\/drug-for-pda-closure-in-newborn-cardiology-mcq\/","og_site_name":"All About Cardiovascular System and Disorders","article_published_time":"2016-11-22T02:47:36+00:00","article_modified_time":"2021-12-20T17:14:41+00:00","author":"Johnson Francis","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Johnson Francis","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/johnsonfrancis.org\/professional\/drug-for-pda-closure-in-newborn-cardiology-mcq\/#article","isPartOf":{"@id":"https:\/\/johnsonfrancis.org\/professional\/drug-for-pda-closure-in-newborn-cardiology-mcq\/"},"author":{"name":"Johnson Francis","@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec"},"headline":"Drug for PDA closure in newborn – Cardiology MCQ","datePublished":"2016-11-22T02:47:36+00:00","dateModified":"2021-12-20T17:14:41+00:00","mainEntityOfPage":{"@id":"https:\/\/johnsonfrancis.org\/professional\/drug-for-pda-closure-in-newborn-cardiology-mcq\/"},"wordCount":235,"commentCount":0,"publisher":{"@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec"},"keywords":["Drug for PDA closure","pharmacological closure of patent ductus arteriosus"],"articleSection":["Cardiology","Cardiology MCQ","DM \/ DNB Cardiology Entrance"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/johnsonfrancis.org\/professional\/drug-for-pda-closure-in-newborn-cardiology-mcq\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/johnsonfrancis.org\/professional\/drug-for-pda-closure-in-newborn-cardiology-mcq\/","url":"https:\/\/johnsonfrancis.org\/professional\/drug-for-pda-closure-in-newborn-cardiology-mcq\/","name":"Drug for PDA closure in newborn - Cardiology MCQ - All About Cardiovascular System and Disorders","isPartOf":{"@id":"https:\/\/johnsonfrancis.org\/professional\/#website"},"datePublished":"2016-11-22T02:47:36+00:00","dateModified":"2021-12-20T17:14:41+00:00","breadcrumb":{"@id":"https:\/\/johnsonfrancis.org\/professional\/drug-for-pda-closure-in-newborn-cardiology-mcq\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/johnsonfrancis.org\/professional\/drug-for-pda-closure-in-newborn-cardiology-mcq\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/johnsonfrancis.org\/professional\/drug-for-pda-closure-in-newborn-cardiology-mcq\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/johnsonfrancis.org\/professional\/"},{"@type":"ListItem","position":2,"name":"Drug for PDA closure in newborn – Cardiology MCQ"}]},{"@type":"WebSite","@id":"https:\/\/johnsonfrancis.org\/professional\/#website","url":"https:\/\/johnsonfrancis.org\/professional\/","name":"All About Cardiovascular System and Disorders","description":"","publisher":{"@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/johnsonfrancis.org\/professional\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":["Person","Organization"],"@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec","name":"Johnson Francis","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g","caption":"Johnson Francis"},"logo":{"@id":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g"},"description":"Former Professor of Cardiology, Calicut Govt. Medical Kozhikode, Kerala, India. Editor-in-Chief, BMH Medical Journal","url":"https:\/\/johnsonfrancis.org\/professional\/author\/jf\/"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts\/21759","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/comments?post=21759"}],"version-history":[{"count":1,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts\/21759\/revisions"}],"predecessor-version":[{"id":52367,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts\/21759\/revisions\/52367"}],"wp:attachment":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/media?parent=21759"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/categories?post=21759"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/tags?post=21759"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}